Tetratherix Ltd
TTX
Company Profile
Business description
Tetratherix Ltd is a biomedical company that has developed an biomaterial platform called Tetramatrix, a proprietary fluid matrix that induces minimal foreign body reaction. The principal activities include development programs in the areas of regenerative medicine and commercialising medical device technology across multiple applications including Bone Regeneration, Tissue Spacing and Tissue Healing.
Contact
34-36 Ralph Street
Unit 29
Alexandria
SydneyNSW2015
AUST: +61 425366073
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
30 June 2026
Employees
Stocks News & Analysis
stocks
AI stocks post big gains in Q3. These are the winners and losers
Alphabet and Teradyne post big gains, while Salesforce and Adobe were down in the quarter.
stocks
12 picks for an income portfolio - Q3 2025 update
Fifteen months in and passive income growth has exceeded my target.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,253.60 | 25.70 | -0.28% |
| CAC 40 | 7,974.85 | 3.07 | 0.04% |
| DAX 40 | 24,385.78 | 7.49 | 0.03% |
| Dow JONES (US) | 46,502.01 | 192.96 | -0.41% |
| FTSE 100 | 9,483.58 | 4.44 | 0.05% |
| HKSE | 26,957.77 | 183.15 | -0.67% |
| NASDAQ | 22,774.54 | 167.13 | -0.73% |
| Nikkei 225 | 47,950.88 | 6.12 | 0.01% |
| NZX 50 Index | 13,531.29 | 42.05 | 0.31% |
| S&P 500 | 6,706.41 | 33.87 | -0.50% |
| S&P/ASX 200 | 8,956.80 | 19.10 | -0.21% |
| SSE Composite Index | 3,882.78 | 20.25 | 0.52% |